Novartis Ag Adr Stock Market Value
| NVS Stock | USD 147.14 2.14 1.48% |
| Symbol | Novartis |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novartis. If investors know Novartis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novartis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.287 | Dividend Share 3.862 | Earnings Share 7.31 | Revenue Per Share | Quarterly Revenue Growth 0.09 |
The market value of Novartis AG ADR is measured differently than its book value, which is the value of Novartis that is recorded on the company's balance sheet. Investors also form their own opinion of Novartis' value that differs from its market value or its book value, called intrinsic value, which is Novartis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novartis' market value can be influenced by many factors that don't directly affect Novartis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novartis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Novartis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novartis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Novartis 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Novartis' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Novartis.
| 10/27/2025 |
| 01/25/2026 |
If you would invest 0.00 in Novartis on October 27, 2025 and sell it all today you would earn a total of 0.00 from holding Novartis AG ADR or generate 0.0% return on investment in Novartis over 90 days. Novartis is related to or competes with AstraZeneca PLC, GlaxoSmithKline PLC, Roche Holding, Bristol Myers, Sanofi ADR, Merck, and Bayer AG. Novartis AG researches, develops, manufactures, and markets healthcare products worldwide More
Novartis Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Novartis' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Novartis AG ADR upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.32 | |||
| Information Ratio | 0.074 | |||
| Maximum Drawdown | 5.29 | |||
| Value At Risk | (2.06) | |||
| Potential Upside | 2.59 |
Novartis Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Novartis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Novartis' standard deviation. In reality, there are many statistical measures that can use Novartis historical prices to predict the future Novartis' volatility.| Risk Adjusted Performance | 0.1022 | |||
| Jensen Alpha | 0.127 | |||
| Total Risk Alpha | 0.0429 | |||
| Sortino Ratio | 0.0739 | |||
| Treynor Ratio | 0.2933 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novartis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Novartis January 25, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1022 | |||
| Market Risk Adjusted Performance | 0.3033 | |||
| Mean Deviation | 0.9054 | |||
| Semi Deviation | 1.04 | |||
| Downside Deviation | 1.32 | |||
| Coefficient Of Variation | 748.67 | |||
| Standard Deviation | 1.31 | |||
| Variance | 1.73 | |||
| Information Ratio | 0.074 | |||
| Jensen Alpha | 0.127 | |||
| Total Risk Alpha | 0.0429 | |||
| Sortino Ratio | 0.0739 | |||
| Treynor Ratio | 0.2933 | |||
| Maximum Drawdown | 5.29 | |||
| Value At Risk | (2.06) | |||
| Potential Upside | 2.59 | |||
| Downside Variance | 1.73 | |||
| Semi Variance | 1.09 | |||
| Expected Short fall | (0.99) | |||
| Skewness | (0.24) | |||
| Kurtosis | 2.15 |
Novartis AG ADR Backtested Returns
Novartis appears to be very steady, given 3 months investment horizon. Novartis AG ADR has Sharpe Ratio of 0.16, which conveys that the firm had a 0.16 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Novartis, which you can use to evaluate the volatility of the firm. Please exercise Novartis' Risk Adjusted Performance of 0.1022, downside deviation of 1.32, and Mean Deviation of 0.9054 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Novartis holds a performance score of 13. The company secures a Beta (Market Risk) of 0.56, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Novartis' returns are expected to increase less than the market. However, during the bear market, the loss of holding Novartis is expected to be smaller as well. Please check Novartis' sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to make a quick decision on whether Novartis' current price movements will revert.
Auto-correlation | 0.61 |
Good predictability
Novartis AG ADR has good predictability. Overlapping area represents the amount of predictability between Novartis time series from 27th of October 2025 to 11th of December 2025 and 11th of December 2025 to 25th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Novartis AG ADR price movement. The serial correlation of 0.61 indicates that roughly 61.0% of current Novartis price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.61 | |
| Spearman Rank Test | 0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 16.73 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Novartis Stock Analysis
When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.